Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole for moderate-to-severe primary Parkinson's disease uncontrolled on levodopa (China phase II)
CTR20132551Phase 2Completed
- Sponsor
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropinirole in Parkinson's disease (PD), sponsored by Zhejiang Huahai Pharmaceutical Co., Ltd.. Started Apr 2014; status: completed.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20132551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132551.